Noile-Immune Biotech Inc. (TYO:4893)
Japan · Delayed Price · Currency is JPY 129.00
-5.00 (-3.73%)
Jun 3, 2026, 3:30 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 5.59 billion as of June 3, 2026. Its market cap has decreased by -7.86% in one year.
Market Cap
5.59B
Enterprise Value
1.84B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
129.00
Market Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 5.59B, a decrease of -81.92%. That is a compound annual growth rate of -44.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 5.59B | -3.01% |
| Dec 30, 2025 | 5.76B | -21.76% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
| Jun 28, 2023 | 30.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 7.30B |
| ADR120S | 7.16B |
| Kubota Pharmaceutical Holdings | 6.69B |
| StemCell Institute | 6.63B |
| CellSource | 6.39B |
| Soiken Holdings | 6.30B |
| TMS Co., Ltd. | 5.87B |
| Chiome Bioscience | 5.52B |